🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
The aim of the study will be to investigate the effect of certolizumab pego...
Status
Completed
Location
Multiple Locations
Start Date
2006-02
Trial ID
NCT00297648
Treatments Being Tested
The study will continue to assess the safety of certolizumab pegol (CDP870)...
Status
Completed
Location
Multiple Locations
Start Date
2006-10
Trial ID
NCT00333788
Treatments Being Tested
To assess the clinical efficacy of subcutaneous (sc) certolizumab pegol adm...
Status
Completed
Location
Multiple Locations
Start Date
2006-04
Trial ID
NCT00308581
Treatments Being Tested
The purpose of the study is to evaluate the ability of subjects who are alr...
Status
Completed
Location
Ra0098 116
Start Date
2017-11-03
Trial ID
NCT03357471
Treatments Being Tested
The study is a Phase 3, multicenter, randomized, double-blind, placebo-cont...
Status
Completed
Location
961
Start Date
2010-03
Trial ID
NCT01087762
Treatments Being Tested
A Multicenter, Open-label Study to Assess the Pharmacokinetics, Safety and ...
Status
Completed
Location
Ra0043 71
Start Date
2012-03-08
Trial ID
NCT01550003
Treatments Being Tested
The purpose of this study is to investigate the efficacy and safety of two ...
Status
Completed
Location
Ps0003 317
Start Date
2015-02-11
Trial ID
NCT02346240
Treatments Being Tested
Phase 3, multicenter, randomized, double-blind, parallel-group, placebo-con...
Status
Completed
Location
961
Start Date
2010-03
Trial ID
NCT01087788
Treatments Being Tested
Patients receive study drug for one year (Part A). If, after the initial ru...
Status
Completed
Location
As0005 2313
Start Date
2015-07
Trial ID
NCT02505542
Treatments Being Tested